Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-441 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,392.5 Cr 0.3% 0.8% -16.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,048.0 Cr 0.5% 4.6% 11.7% Stock Analytics
DIVIS LABORATORIES ₹177,179.0 Cr -0.6% 2.2% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,804.0 Cr 3.2% 8.1% 43.9% Stock Analytics
CIPLA ₹117,642.0 Cr 1.1% 5.6% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹112,368.0 Cr -0.3% 5.6% -0.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.3%

0.8%

-16.5%

SENSEX

0.7%

4.4%

-5.6%


You may also like the below Video Courses